(Q22009531)

GOA release 2020-03-11

K Y Yu

1

K Y

Yu

1 reference

7 February 2023

B Kwon

2

0 references

J Ni

3

author given names

J

author last names

Ni

1 reference

7 February 2023

Y Zhai

4

author given names

Y

author last names

Zhai

1 reference

7 February 2023

R Ebner

5

author given names

R

author last names

Ebner

1 reference

7 February 2023

B S Kwon

Journal of Biological Chemistry

6

0 references

language of work or name

English

0 references

publication date

14 May 1999

0 references

published in

0 references

volume

274

0 references

page(s)

13733-6

0 references

issue

20

0 references

cites work

Tumor necrosis factor receptor superfamily members and their ligands

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Recent advances in tumor necrosis factor and CD40 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733

Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.20.13733